fda ban on compounded semaglutide compounding news alerts health care providers, compounders and patients of dosing errors associated with injectable products The FDA's Decision to – FDA approves obesity drug that – FDA ban on compounded semaglutide

A reliable supplier should provide third-party laboratory testing with HPLC and mass spectrometry verification, certificates of analysis showing purity above 95%, proper lyophilized packaging with appropriate storage instructions, domestic shipping from within Canada for faster delivery and reduced customs risk, and responsive customer support that can answer technical questions about their products

A new weight loss medication helps patients keep weight off and supports healthy lifestyle changes

The lawsuit, which Fierce Healthcare disclosed, alleges the firms manufactured and sold what the complaint characterizes as modern-day snake oil: compounded oral tirzepatide tablets with no demonstrated mechanism of absorption or efficacy. MEDVi is not named as a defendant, but the complaint alleges the plaintiff purchased the pills through MEDVi, which it describes as one of dozens of consumer-facing telehealth storefronts in a network operated by OpenLoop

doi:10.1007/s00726-017-2493-3 Khanna P, Aeri BT